Our previous studies showed that the anti-apoptotic protein HURP (hepatoma upregulated protein) and PTMA (prothymosin-α) [2, 3], which are upregulated in human HCC [4, 5], represent important targets of sorafenib in HCC cells cultured in vitro [3, 6]. Here, PTMA is linked to hepatocellular carcinoma.